Johnson & Johnson Share Price Sao Paulo

Equities

JNJB34

BRJNJBBDR002

Pharmaceuticals

Market Closed - Sao Paulo 01:35:00 15/05/2024 am IST 5-day change 1st Jan Change
51.8 BRL +0.15% Intraday chart for Johnson & Johnson +3.23% +2.78%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 88.37B 452B 7,374B Sales 2025 * 90.78B 464B 7,575B Capitalization 364B 1,863B 30,400B
Net income 2024 * 22.04B 113B 1,839B Net income 2025 * 23.09B 118B 1,927B EV / Sales 2024 * 4.04 x
Net cash position 2024 * 7B 35.77B 584B Net cash position 2025 * 21.07B 108B 1,759B EV / Sales 2025 * 3.78 x
P/E ratio 2024 *
16.8 x
P/E ratio 2025 *
15.9 x
Employees 1,31,900
Yield 2024 *
3.19%
Yield 2025 *
3.33%
Free-Float 77.08%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.15%
1 week+3.23%
Current month+3.50%
1 month+2.84%
3 months+0.48%
6 months+8.21%
Current year+2.78%
More quotes
1 week
50.58
Extreme 50.58
52.05
1 month
49.65
Extreme 49.65
52.05
Current year
49.65
Extreme 49.65
54.37
1 year
47.60
Extreme 47.6
58.25
3 years
47.60
Extreme 47.6
66.01
5 years
32.10
Extreme 32.0967
66.01
10 years
14.87
Extreme 14.8707
66.01
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 01/89/01
Director of Finance/CFO 57 01/98/01
Chief Tech/Sci/R&D Officer 58 05/19/05
Members of the board TitleAgeSince
Director/Board Member 70 25/19/25
Director/Board Member 72 19/14/19
Director/Board Member 70 22/09/22
More insiders
Date Price Change Volume
14/24/14 51.8 +0.15% 3,683
13/24/13 51.72 +0.17% 8,413
10/24/10 51.63 +0.86% 1,901
09/24/09 51.19 +1.43% 4,649
08/24/08 50.47 +0.58% 7,844

Delayed Quote Sao Paulo, May 15, 2024 at 01:35 am IST

More quotes
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
151.4 USD
Average target price
173.3 USD
Spread / Average Target
+14.46%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW